Activation of the purinergic receptor P2X7 improves hepatosteatosis by promoting lipophagy

被引:6
作者
Dong, Zizhi [1 ]
Wei, Yujia [2 ]
Tao, Min [1 ]
Zhang, Lili [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing 400010, Peoples R China
[2] Mayo Clin, Dept Radiol, Rochester, MN USA
基金
中国国家自然科学基金;
关键词
autophagy; lipophagy; nonalcoholic fatty liver disease; VACUOLAR; AUTOPHAGY; AXIS;
D O I
10.1002/1873-3468.14207
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is a global health problem that develops through unclear molecular mechanisms. The P2X7 purinergic receptor (P2RX7) is an ATP-gated ion channel that belongs to the P2XR family. Thus far, studies on P2RX7 in NAFLD have been largely contradictory. Integrating experiments and modeling, we elucidate the dynamic processes of lipid droplet fusion and degradation following regulation of P2RX7. We show that activation of P2RX7 can activate the AMPK/ULK1 pathway to promote autophagosome generation and lysosomal degradation of autophagosomes. Inhibiting P2RX7 has the opposite effect. Notably, we find that lipid droplets become larger by the fusion of dysfunctional lysosomes but cannot be degraded by them following P2RX7 inhibition. Our study provides evidence that P2RX7 activation improves NAFLD by promoting lipophagy.
引用
收藏
页码:2768 / 2780
页数:13
相关论文
共 36 条
  • [1] The P2X7 receptor: A main player in inflammation
    Adinolfi, Elena
    Giuliani, Anna Lisa
    De Marchi, Elena
    Pegoraro, Anna
    Orioli, Elisa
    Di Virgilio, Francesco
    [J]. BIOCHEMICAL PHARMACOLOGY, 2018, 151 : 234 - 244
  • [2] The loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis
    Arguin, Guillaume
    Bourzac, Jean-Francois
    Placet, Morgane
    Molle, Caroline M.
    Paquette, Michel
    Beaudoin, Jean-Francois
    Rousseau, Jacques A.
    Lecomte, Roger
    Plourde, Melanie
    Gendron, Fernand-Pierre
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [3] Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes
    Ashrafi, K
    Chang, FY
    Watts, JL
    Fraser, AG
    Kamath, RS
    Ahringer, J
    Ruvkun, G
    [J]. NATURE, 2003, 421 (6920) : 268 - 272
  • [4] The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
    Burnstock, Geoffrey
    Knight, Gillian E.
    [J]. PURINERGIC SIGNALLING, 2018, 14 (01) : 1 - 18
  • [5] Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis
    Chandrashekaran, Varun
    Das, Suvarthi
    Seth, Ratanesh Kumar
    Dattaroy, Diptadip
    Alhasson, Firas
    Michelotti, Gregory
    Nagarkatti, Mitzi
    Nagarkatti, Prakash
    Diehl, Anna Mae
    Chatterjee, Saurabh
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2016, 1862 (01): : 32 - 45
  • [6] The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells
    da Silva, Henrique Borges
    Beura, Lalit K.
    Wang, Haiguang
    Hanse, Eric A.
    Gore, Reshma
    Scott, Milcah C.
    Walsh, Daniel A.
    Block, Katharine E.
    Fonseca, Raissa
    Yan, Yan
    Hippen, Keli L.
    Blazar, Bruce R.
    Masopust, David
    Kelekar, Ameeta
    Vulchanova, Lucy
    Hogquist, Kristin A.
    Jameson, Stephen C.
    [J]. NATURE, 2018, 559 (7713) : 264 - +
  • [7] Regulation of lipid droplets by autophagy
    Dong, Hanqing
    Czaja, Mark J.
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2011, 22 (06) : 234 - 240
  • [8] Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
    Egan, Daniel F.
    Shackelford, David B.
    Mihaylova, Maria M.
    Gelino, Sara
    Kohnz, Rebecca A.
    Mair, William
    Vasquez, Debbie S.
    Joshi, Aashish
    Gwinn, Dana M.
    Taylor, Rebecca
    Asara, John M.
    Fitzpatrick, James
    Dillin, Andrew
    Viollet, Benoit
    Kundu, Mondira
    Hansen, Malene
    Shaw, Reuben J.
    [J]. SCIENCE, 2011, 331 (6016) : 456 - 461
  • [9] A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
    Eslam, Mohammed
    Newsome, Philip N.
    Sarin, Shiv K.
    Anstee, Quentin M.
    Targher, Giovanni
    Romero-Gomez, Manuel
    Zelber-Sagi, Shira
    Wong, Vincent Wai-Sun
    Dufour, Jean-Francois
    Schattenberg, Joern M.
    Kawaguchi, Takumi
    Arrese, Marco
    Valenti, Luca
    Shiha, Gamal
    Tiribelli, Claudio
    Yki-Jarvinen, Hannele
    Fan, Jian-Gao
    Gronbaek, Henning
    Yilmaz, Yusuf
    Cortez-Pinto, Helena
    Oliveira, Claudia P.
    Bedossa, Pierre
    Adams, Leon A.
    Zheng, Ming-Hua
    Fouad, Yasser
    Chan, Wah-Kheong
    Mendez-Sanchez, Nahum
    Ahn, Sang Hoon
    Castera, Laurent
    Bugianesi, Elisabetta
    Ratziu, Vlad
    George, Jacob
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 202 - 209
  • [10] Redefining non-alcoholic fatty liver disease: what's in a name?
    不详
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (05): : 419 - 419